FOXO3 and hepatocellular carcinoma: miR-498 did not inhibit the expression of FOXO3a in hepatocellular carcinoma, despite carrying a binding site that is complementary to that in the FOXO3s 3’-UTR (40); this finding is substantially different to that reported in most prior studies.